ImmunyX
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
210 W 90th St, New York, New York, 10024...Website
www.immunyx.comRevenue
<$5 MillionIndustry
About ImmunyX
ImmunyX is a drug development company that focuses on pioneering new approaches to immune modulation, specifically targeting neutrophils to alter their disease-causing activity. The company aims to provide effective and safe treatments for various large market diseases, including COPD, cancer, colitis, and arthritis, where neutrophil deregulation plays a significant role. Utilizing novel pharmacological techniques, ImmunyX seeks to overcome the challenges faced by existing neutrophil therapies, which have yet to receive FDA approval. Their innovative technology positions them as a leader in the field of neutrophil modulation.Explore more
ImmunyX Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to ImmunyX
Compare insights from companies similar to ImmunyX, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
ImmunyX Tech Stack
A closer look at the technologies used by ImmunyX
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ImmunyX
Sign Up For FreeTo access detailed company insights
ImmunyX is a drug development company that focuses on pioneering new approaches to immune modulation, specifically targeting neutrophils to alter their disease-causing activity. The company aims to provide effective and safe treatments for various large market diseases, including COPD, cancer, colitis, and arthritis, where neutrophil deregulation p... Read More
